Contract Research Organization WCCT Global to Attend the 2013 American Academy of Ophthalmology Conference in New Orleans

October 23, 2013

WCCT Global will be at the 2013 American Academy of Ophthalmology Conference and will be available to discuss the ophthalmology clinical research that has taking place at WCCT Global and will have information on the new ophthalmology research site.

Costa Mesa, CA (PRWEB) October 23, 2013

WCCT Global, a full-service contract research organization announced today that they will be in attendance at the 2013 American Academy of Ophthalmology (AAO) Conference to discuss significant changes in the realm of ophthalmic clinical research. Dr. Michael A. Sheety has recently been appointed WCCT Global’s Medical and Surgical Director of Ophthalmology and Aesthetics, and is a leading investigator for ophthalmic and cosmetic research. Dr. Sheety has been involved in many early and late phase studies and will be exhibiting the capabilities of WCCT Global Ophthalmology Research Center’s (WORC) at AAO. Dr. Sheety brings a wealth of knowledge to the conference and sponsors will be able to hold in-depth discussions about custom designs and strategies for their upcoming ophthalmic and cosmetic research studies. WCCT Global will be at booth # 4945. WCCT Global’s Chief Operating Officer, Jon Rojas, stated, “I am thrilled that Dr. Sheety will be attending AAO this year and representing the WCCT Global organization. I am excited for clients to speak with Dr. Sheety and learn how WORC’s fully focused and dedicated ophthalmology center along with WCCT Global’s complete CRO service offerings can advance the development of therapies and devices for the eye.”

More about WCCT Global:

WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

If you would like to request information about how WCCT Global can assist your organization with a clinical study, please CLICK HERE.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11258884.htm

Source: prweb

comments powered by Disqus